每年專案
個人檔案
學歷
- 1978-1985 臺北醫學大學醫學系學士
經歷
- 2023.08- 臺北醫學大學校長
- 2022.02- 臺北醫學大學臨床基因體學暨蛋白質體學碩士學位學程教授
- 2020.02- 臺北醫學大學心智意識與腦科學研究博士學位學程教授
- 2015.08- 臺北醫學大學生醫材料暨組織工程研究所教授
- 2014.08- 臺北醫學大學轉譯醫學博士學位學程教授
- 2014.08- 臺北醫學大學臨床醫學研究所教授
- 2023.04-2023.07 臺北醫學大學管理發展中心主任
- 2022.01-2023.07 臺北醫學大學副校長
- 2020.08-2023.07 臺北醫學大學泌尿腎臟研究中心主任
- 2019.08-2020.07 新國民醫院籌備處院長
- 2017.08-2021.12 衛生福利部雙和醫院院長
- 2015.01-2017.07 臺北醫學大學管理發展中心主任
- 2013.11-2014.12 臺北醫學大學醫學院副院長
- 2012.12-2014.12 臺北醫學大學醫學系副主任
- 2012.06- 臺北醫學大學內科學科教授
- 2012.12-2014.12 臺北醫學大學附設醫院教學副院長
- 2008.08-2010.07 臺北醫學大學生理學科教授
- 2007 長庚大學(教字第015586號) 教育部部定教授
- 2004-2011 長庚醫院教授
- 2004-2008 臺北醫學大學生理學科兼任副教授
- 1999-2004 長庚醫院,長庚大學副教授
- 1997-1999 長庚醫院,長庚大學助理教授
- 1995-1997 長庚醫院,長庚大學講師
- 1986.06-2012.05 長庚醫院學術組教授兼主治醫師
獎項
- 2019 臺北醫學大學附屬醫院研究計畫獎
- 2008 獲選商業周刊 好醫師推薦榜
- 2004 Award for best article Taiwan Society of Transplantation
- 2004 Award for best research Taiwan Society of Nephrology
- 2003-2011 Best teaching attending physician
- 2002 Best medical chart attending physician
- 2001 Award for best article Taiwan Society of Transplantation
- 2000 Taiwan National Science Council Research Award
- 2000 Young Investigator Award ERA-EDTA (European Renal Association – European Dialysis and Transplant Association), Nice, France
- 2000 Award for best abstract ERA-EDTA (European Renal Association – European Dialysis and Transplant Association), Nice, France
- 2000 Investigator Award of international forum on Angiotensin II receptor antagonist, London, UK
- 1999 Investigator Award of international forum on Angiotensin II receptor antagonist, Monte Carlo, Monaco
- 1998 Asian Young Investigator Award ISPD (International society of peritoneal dialysis), Seoul, Korea
研究興趣
- 腎臟生理學,細胞生物學與細胞生理學
- 體液與電解質疾病
- 臨床腎臟科學
- 腎臟替代療法
指紋
查看啟用 Mai-Szu Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
以多體學研究整合宿主基因與腸道微生物開發阻斷心腎代謝腎症候群之治療策略(1/4)
Wu, M.-S. (PI)
5/1/24 → 4/30/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
-
-
-
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy
Ho, S. Y., Kao, C. C., Chang, C. M., Chou, Y. C., Luo, W. T., Chou, W. H., Tsai, I. L., Wu, M. S. & Chang, W. C., 12月 2024, 於: Biomarker Research. 12, 1, 23.研究成果: 雜誌貢獻 › 快報 › 同行評審
開啟存取 -
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial
The SANCTUARY Study Investigators, 2024, (接受/付印) 於: Journal of the American Society of Nephrology. 10.1681/ASN.0000000534.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Insights of Fabry disease: Expert consensus approach for screening, diagnosis, and multidisciplinary management in chronic kidney disease
Lin, C. J., Yang, F. J., Wu, C. J., Wu, M. J. & Wu, M. S., 2024, (接受/付印) 於: Journal of the Formosan Medical Association.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
開啟存取 -
Interprofessional Differences in Multidimensional Self-Efficacy Associated With Professional Performance in Nephrology During Case-Based Learning
Chao, C. T., Wu, M. Y., Hung, K. Y., Wu, M. S. & Liang, J. C., 4月 2024, 於: Kidney International Reports. 9, 4, p. 877-887 11 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3–5: A real-world retrospective cohort study in Taiwan
Shao, Y. H. J., Chen, W. T., Yu, S. M. W., Tsou, L. L. A., Hsu, Y. H., Wu, M. S., Kao, Y. H., Chou, C. L. & Hsiao, P. J., 2024, 於: International Journal of Medical Sciences. 21, 11, p. 2109-2118 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Additional file 4: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
Hsu, Y.-W. (Creator), Chang, W.-C. (Creator), Wong, H.S.-C. (Creator), Kao, C.-C. (Contributor), Chang, W.-C. (Creator), Wu, M.-S. (Contributor), Liu, X. (Creator) & Chang, C.-M. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3824278_d4.v1, https://doi.org/10.6084%2Fm9.figshare.c.3824278_d4.v1
資料集: Dataset
-
Additional file 1: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
Hsu, Y.-W. (Creator), Wong, H.S.-C. (Creator), Chang, W.-C. (Creator), Wu, M.-S. (Contributor), Liu, X. (Creator), Chang, W.-C. (Creator), Kao, C.-C. (Contributor) & Chang, C.-M. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3824278_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3824278_d1.v1
資料集: Dataset
-
Additional file 3: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
Chang, W.-C. (Creator), Chang, W.-C. (Creator), Liu, X. (Creator), Hsu, Y.-W. (Creator), Kao, C.-C. (Contributor), Wong, H.S.-C. (Creator), Chang, C.-M. (Creator) & Wu, M.-S. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3824278_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3824278_d3.v1
資料集: Dataset
-
Additional file 6: of V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
Wu, M.-S. (Contributor), Chang, W.-C. (Creator), Kao, C.-C. (Contributor), Hsu, Y.-W. (Creator), Chang, W.-C. (Creator), Chang, C.-M. (Creator), Liu, X. (Creator) & Wong, H.S.-C. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3824278_d6.v1, https://doi.org/10.6084%2Fm9.figshare.c.3824278_d6.v1
資料集: Dataset
-
Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients
Kao, C.-C. (Contributor), Cheng, S.-Y. (Creator), Wang, Y.-J. (Creator), Chien, S.-C. (Creator), Hsu, Y.-W. (Creator), Wu, M.-Y. (Creator), Lu, H.-F. (Contributor), Nam, S. (Creator), Sun, T. (Creator), Wu, M.-S. (Creator) & Chang, W.-C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4531100.v1, https://doi.org/10.6084%2Fm9.figshare.c.4531100.v1
資料集: Dataset